Thierry Laugel is the founder and Managing Partner of Kurma Partners. See sector focus and contact routes.
Thierry Laugel is the founder and Managing Partner of Kurma Partners, a Paris-based venture capital firm he established in 2009 that specializes in healthcare and life sciences. He holds a PhD in Pharmacology and an MBA from INSEAD, with a career beginning in R&D before transitioning to investment roles at Caisse des Dépôts and AGF Private Equity. Kurma Partners targets early-stage and growth-stage ventures in therapeutics, diagnostics, and digital health, primarily across Europe. The firm manages approximately EUR 350 million and often builds its own companies rather than just following other investors. Notable portfolio companies include PathoQuest, a diagnostics revolution, and THX Pharma, which secured a major agreement worth up to EUR 173 million. Laugel is also Chairman of Argobio, a venture model designed to build Europe’s next biotech champions. He is described as a pioneer among European biotechnology investors who runs a VC that actively grows its own companies.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in France.
Investors like Thierry Laugel · Full investor directory · Investor access · Company funding database